Dual effects of erdosteine on hemostasis via its different metabolites in young rats
dc.authorid | Oktar, Suleyman/0000-0003-0151-5981 | |
dc.contributor.author | Arica, Vefik | |
dc.contributor.author | Tutanc, Murat | |
dc.contributor.author | Ozturk, Oktay Hasan | |
dc.contributor.author | Arica, Secil | |
dc.contributor.author | Basarslan, Fatmagul | |
dc.contributor.author | Erden, Ersin Sukru | |
dc.contributor.author | Oktar, Suleyman | |
dc.date.accessioned | 2024-09-18T20:19:49Z | |
dc.date.available | 2024-09-18T20:19:49Z | |
dc.date.issued | 2011 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Aim: In the study, we examined erdosteine's effects on platelet functions and coagulation. Materials and methods: A total 29 young albino Wistar rats were divided into four groups. Control rats (n = 6) were given saline; Group I rats (n = 7) were given 3 mg/kg erdosteine by oral gavage for 3 days; Group 2 rats (n = 7) were given 10 mg/kg erdosteine by oral gavage for 3 days; and Group 3 rats (n = 9) were given 30 mg/kg erdosteine for 3 days. Twenty-four hours after the final dose, blood samples were drawn from a portal vein. Prothrombin time (PT), activated partial thromboplastin time (aPTT) and international normalized ratio (INR) were measured, and platelet counts were examined in a peripheral blood smear by light microscopy. Results: PT and INR values of Group I increased compared to the controls but did not change in Group 3. Hemostatic parameters were not measured in Group 2 because the blood samples in Group 2's tubes clotted rapidly. Platelet counts of the peripheral blood from Group 2 were low but were normal in other groups. Conclusion: We have concluded erdosteine may disrupt hemostasis parameters by its different metabolites in patients. Erdosteine has dual effects on hemostasis via its different metabolites, which occur in different doses. | en_US |
dc.identifier.doi | 10.1177/0960327110396526 | |
dc.identifier.endpage | 1648 | en_US |
dc.identifier.issn | 0960-3271 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.pmid | 21247989 | en_US |
dc.identifier.scopus | 2-s2.0-80054854936 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1644 | en_US |
dc.identifier.uri | https://doi.org/10.1177/0960327110396526 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/9877 | |
dc.identifier.volume | 30 | en_US |
dc.identifier.wos | WOS:000295812200025 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Ltd | en_US |
dc.relation.ispartof | Human & Experimental Toxicology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | erdosteine | en_US |
dc.subject | hemostasis | en_US |
dc.subject | bleeding | en_US |
dc.subject | clotting | en_US |
dc.title | Dual effects of erdosteine on hemostasis via its different metabolites in young rats | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1